0001744905-26-000001.txt : 20260316 0001744905-26-000001.hdr.sgml : 20260316 20260316123820 ACCESSION NUMBER: 0001744905-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260316 DATE AS OF CHANGE: 20260316 EFFECTIVENESS DATE: 20260316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EP Life Sciences Ltd. CENTRAL INDEX KEY: 0001744905 ORGANIZATION NAME: EIN: 981430795 STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-315691 FILM NUMBER: 26755514 BUSINESS ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: (212) 891-8625 MAIL ADDRESS: STREET 1: 375 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10152 D/A 1 primary_doc.xml X0708 D/A LIVE 0001744905 EP Life Sciences Ltd. 375 PARK AVENUE NEW YORK NY NEW YORK 10152 (212) 891-8625 CAYMAN ISLANDS None None Other Cayman Islands exempted company with limited liability true Kabir S Kapoor 375 Park Avenue, 21st Floor NEW YORK NY NEW YORK 10152 Director Michael Fierro 375 Park Avenue, 21st Floor New York NY NEW YORK 10152 Director Marty Piccinich 375 Park Avenue, 21st Floor NEW YORK NY NEW YORK 10152 Director Gregory Link Landmark Square, 1st Floor 64 Earth Close, Box 715 Grand Cayman E9 CAYMAN ISLANDS KY1-1107 Director c/o ICG Management Limited Ralph Woodford Landmark Square, 1st Floor 64 Earth Close, Box 715 Grand Cayman E9 CAYMAN ISLANDS KY1-1107 Director c/o ICG Management Limited Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000899140-25-000445 2021-07-01 true true true false 100000 Indefinite 52817488 Indefinite false 22 0 0 0 false EP Life Sciences Ltd. /s/ Michael Sancilio Michael Sancilio Authorized Signatory 2026-03-16